Qrons licenses 3D printing tech from Dartmouth Uni
US biotechnology company Qrons has obtained a world exclusive licence for IP related to 3D printable materials in the fields of human and animal health from Dartmouth University.
Under the terms of the agreement, Qrons will pay an initial and annual licence fee, as well as royalties on product sales.
Qrons said it is using the 3D process covered by the patent, titled “mechanically interlocked molecules-based materials for 3D printing”, as part of its “injury-specific 3D printable implants to treat penetrating brain injuries”.
Jonah Meer, CEO of Qrons, said that there was a “great need for our promising treatments, and this technology is an integral part of our work to develop innovative 3D printable, biocompatible advanced materials”.
Ido Merfeld, head of product at the company, added that the “IP covered by this licence has been instrumental in helping us advance our research on the treatment of penetrating brain injuries”.
“We believe combining Qrons’ proprietary hydrogel with customisable 3D printing capabilities is an innovative approach to treating traumatic brain injuries, for which there are limited treatments,” Merfeld added.
Johnson & Johnson announced last year that it had acquired German 3D printing company Emerging Implant Technologies (EIT).
According to J&J, the purpose of the deal was to integrate EIT’s 3D-printed products into its orthopaedic interbody implant portfolio.
Did you enjoy reading this story? Sign up to our free newsletters and get stories like this sent straight to your inbox.
